Management of cancer of the retromolar trigone.
Treatment of cancer of the retromolar trigone (RMT) is controversial. While early lesions may be managed with single-modality, more advanced lesions may invade the mandible, pterygoid musculature, and the adjacent mucosa of the tonsillar pillar and soft palate, therefore making therapeutic decisions more complicated. Treatment options traditionally include surgical resection, external beam irradiation, and combined modality therapy. The choice of therapy is dependent on the extent of the tumor, nodal metastasis, and the medical status of the patient and comorbid conditions. The following review outlines the current issues relevant to the diagnosis and therapy of patients with RMT malignancy.
Genden
Eric M
EM
Department of Otolaryngology-Head and Neck Surgery, Mount Sinai School of Medicine, New York, NY, USA.
Ferlito
Alfio
A
Shaha
Ashok R
AR
Rinaldo
Alessandra
A
D006801:Humans; D009062:Mouth Neoplasms / Q000175:diagnosis / Q000628:therapy*; D019647:Oral Surgical Procedures / Q000379:methods; D011379:Prognosis